Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (7) , 1194-1200
- https://doi.org/10.1016/s0149-2918(02)80029-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitorsThe British Journal of Psychiatry, 2001
- Mirtazapine compared with paroxetine in major depression.The Journal of Clinical Psychiatry, 2000
- Efficacy of Venlafaxine and Predictors of Response in a Prospective Open-Label Study of Patients With Treatment-Resistant Major DepressionJournal of Clinical Psychopharmacology, 2000
- The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymiaInternational Clinical Psychopharmacology, 2000
- Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholiaInternational Clinical Psychopharmacology, 2000
- Venlafaxine in Treatment-Resistant Major Depression: A Canadian Multicenter, Open-Label TrialJournal of Clinical Psychopharmacology, 1999
- Venlafaxine and paroxetine in treatment-resistant depressionThe British Journal of Psychiatry, 1999
- Loss of Antidepressant Efficacy During Maintenance TherapyThe Journal of Clinical Psychiatry, 1998
- Two actions are better than oneInternational Clinical Psychopharmacology, 1996
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960